New York, NY: Older patients are more likely to purchase sublingual formulations of cannabis, as well as products higher in CBD, according to an analysis of sales data published in the journal Cannabis and Cannabinoid Research.
Researchers from New York University’s School of Medicine analyzed invoice data from nearly 6,000 patients ages 50 and older who patronized a state-licensed medical dispensary in New York state.
Authors reported, “Older adults were more likely to use sublingual tincture versus other consumption methods, to use products with a lower THC:CBD ratio, and to begin cannabis treatment with a lower THC and higher CBD dose compared with younger age groups.”
The findings are consistent with those of prior surveys showing that older patients are more likely to use tinctures and are less likely to use vaporizer devices. Because the sale of cannabis flower was prohibited in New York at the time the study was conducted, authors could not assess patients’ preference for it. However, prior studies have determined that botanical cannabis preparations are most likely to be favored by all age groups.
Numerous studies have identified a significant uptick in the percentage of older Americans using medical cannabis. According to data published in October in the Journal of the American Geriatric Society, over half of seniors consuming medical cannabis initiated their use as older adults.
Full text of the study, “Patterns of medical cannabis use among older adults from a cannabis dispensary in New York state,” appears in Cannabis and Cannabinoid Research.